2020
DOI: 10.1021/acsomega.0c00062
|View full text |Cite
|
Sign up to set email alerts
|

Paper-Based Platform with an In Situ Molecularly Imprinted Polymer for β-Amyloid

Abstract: Alzheimer's disease (AD) is one of the most common forms of dementia affecting millions of people worldwide. Currently, an easy and effective form of diagnosis is missing, which significantly hinders a possible improvement of the patient's quality of life. In this context, biosensors emerge as a future solution, opening the doors for preventive medicine and allowing the premature diagnosis of numerous pathologies. This work presents a pioneering biosensor that combines a bottom-up design approach using paper a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 30 publications
(15 citation statements)
references
References 59 publications
(127 reference statements)
0
15
0
Order By: Relevance
“…Chen et al [ 75 ] also developed a paper-based electrical sensor with molecularly imprinted glucose-recognition sites for the determination of various glucose concentrations in bovine blood solutions. Pereira et al [ 76 ] developed an MIP paper-based platform to detect β-amyloid, a biomarker of Alzheimer’s disease present in blood. These new MIP-PAD sensors have great potential for point-of-care detection applications.…”
Section: Paper-based Molecular-imprinting Technologymentioning
confidence: 99%
“…Chen et al [ 75 ] also developed a paper-based electrical sensor with molecularly imprinted glucose-recognition sites for the determination of various glucose concentrations in bovine blood solutions. Pereira et al [ 76 ] developed an MIP paper-based platform to detect β-amyloid, a biomarker of Alzheimer’s disease present in blood. These new MIP-PAD sensors have great potential for point-of-care detection applications.…”
Section: Paper-based Molecular-imprinting Technologymentioning
confidence: 99%
“…In short, many kinds of MIP-based biosensor analysis developments have been reported for special targets such as paracetamol (acetaminophen) in plasma (Alanazi et al 2021 ), glycoprotein in human serum sample (You et al 2017 ), uric acid in serum and urine (Göçenoğlu Sarıkaya et al 2017 ), heart-fatty acid binding protein in human serum, human plasma, and bovine serum (Sanati et al 2021 ), β ‑amyloid in serum (Pereira et al 2020 ) and α synuclein in human brain organoids (Lee et al 2020 ) with high accuracy and recovery which may lead to clinical usage as fast and reproducible approaches. The use of MIPs in biological sensing has also been the subject of recent several review studies (Batista et al 2021 ; Kadhem et al 2021 ; Ramanavicius et al 2022 ) (Fig.…”
Section: Mip In Bioanalysismentioning
confidence: 99%
“…MIP has also been used in the work of Ozcan and coauthors (2020) and Pereira and coauthors (2020), both aimed to detect A β 42 [ 52 , 53 ]. The classic electrochemical biosensor construction, a glassy carbon electrode with delaminated titanium carbide MXene and multiwalled carbon nanotubes composite covered by MIP, was prepared in the work of Ozcan and coauthors [ 52 ].…”
Section: Electrochemical Biosensors In Diagnosis Of Alzheimer's Diseasementioning
confidence: 99%
“…The classic electrochemical biosensor construction, a glassy carbon electrode with delaminated titanium carbide MXene and multiwalled carbon nanotubes composite covered by MIP, was prepared in the work of Ozcan and coauthors [ 52 ]. On the other hand, in the work of Pereira and coauthors, an innovative paper-based platform for carrying MIP was prepared [ 53 ]. Although Ozcan and coauthors have achieved a much lower limit of detection as well as better sensitivity, the construction of Pereira and coauthor is unique in its simplicity and low cost.…”
Section: Electrochemical Biosensors In Diagnosis Of Alzheimer's Diseasementioning
confidence: 99%